Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
Financial Results:
Alkem Laboratories Ltd reported Revenues for Q1FY24 of ₹2,968.00 Crores up from ₹2,576.00 Crore year on year, a rise of 15.22%.
Total Expenses for Q1FY24 of ₹2,681.00 Crores up from ₹2,475.00 Crores year on year, a rise of 8.32%.
Consolidated Net Profit of ₹288.00 Crores up 119.85% from ₹131.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹23.98, up 124.53% from ₹10.68 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.